Echo Street Capital Management LLC Fate Therapeutics Inc Transaction History

Echo Street Capital Management LLC

  • $0
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$9.86 - $23.83 $125,369 - $302,998
12,715 Added 34.97%
49,073 $495,000
Q3 2022

Nov 14, 2022
BUY
$21.04 - $36.06 $764,972 - $1.31 Million
36,358 New
36,358 $815,000
Q3 2021

Nov 15, 2021
SELL
$59.27 - $95.73 $169,808 - $274,266
-2,865 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$67.25 - $92.52 $118,091 - $162,465
-1,756 Reduced 38.0%
2,865 $249,000
Q1 2021

May 17, 2021
BUY
$72.16 - $117.4 $333,451 - $542,505
4,621 New
4,621 $381,000

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $161M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Echo Street Capital Management LLC Portfolio

Follow Echo Street Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Echo Street Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email